Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4236 participants
OBSERVATIONAL
2010-07-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Second Survey of Intensive Care in India
NCT03631927
Integrated Pulmonary Index as a Predictor of Respiratory Compromise in Critically Ill Patients
NCT06395532
Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19)
NCT04948242
Sepsis in ICU:Causes and Outcomes of Sepsis in Diabetics Versus Non Diabetics in Assiut University Hospital
NCT04015752
Burden, Mortality and Supply Costs in Intensive Care Unit Patients
NCT04094428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Case-mix, severity of illness, prevalence of infection, hemodynamic monitoring and therapy, mechanical ventilation practices, nutrition and outcome
* Seasonal and regional variations in the above
* Epidemiology and variations in antibiotic use
* Patterns of microorganisms and outcome
* Prevalence and outcome of specific tropical febrile illnesses, including malaria, dengue fever, leptospirosis, scrub typhus
* Prevalence and outcome of toxins and poisonings
* Relation of ICU and hospital organizational issues to prevalence of infection and outcome
* Organisation of intensive care services
* End of life - Ethical decisions
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU patients
All patients present in the ICU on the selected days
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indian Society of Critical Care Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Indian Society of Critical Care Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jigeeshu Divatia, MD
Role: STUDY_CHAIR
Indian Society of Critical Care Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tata Memorial Hospital
Mumbai, Maharashtra, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISCCM01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.